LY686017

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY686017, covering 2007-02-13 to 2010-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Effect of LY686017 on Alcohol Craving [Phase 2]